43 results on '"Forman, S."'
Search Results
2. A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation
3. Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation
4. Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome
5. Mycophenolate mofetil-based salvage as acute GVHD prophylaxis after early discontinuation of tacrolimus and/or sirolimus
6. Sclerodermatous chronic GVHD in patients receiving tyrosine kinase inhibitors after allogeneic hematopoietic cell transplantation
7. Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase
8. Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies
9. A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant
10. Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study
11. Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine–melphalan conditioning for treatment of mature T-cell lymphomas
12. A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia
13. Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia
14. Nontyphoidal Salmonella infection among recipients of hematopoietic SCT
15. The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
16. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
17. Late onset of EBV-driven PTLD/Burkitt lymphoma/leukemia in a patient 10 years after allogeneic stem cell transplant for AML
18. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation
19. High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors
20. Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors
21. Allogeneic transplantation for ALL in adults
22. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
23. A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction
24. Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells
25. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study
26. Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma
27. Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML
28. Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli
29. Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies
30. Should HIV-positive patients with lymphoma be offered stem cell transplants?
31. Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer
32. Aprepitant (Emend) significantly increases sirolimus levels in patients undergoing allogeneic hematopoietic SCT
33. Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality
34. Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD
35. National scientific medical meeting 1995 abstracts: Oral presentations
36. Measurement of quality of life in bone marrow transplantation survivors
37. Autologous hematopoietic cell transplantation for high-risk ALL
38. Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor
39. Neuronal, physiological and brain–behavioural abnormalities in opiate-addicted individuals
40. Outcome of bone marrow transplantation in patients with extramedullary involvement of acute leukemia
41. High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignancies
42. Allogeneic bone marrow transplantation for high risk non-hodgkin's lymphoma during first complete remission
43. Allogeneic bone marrow transplantation as primary therapy for chronic myelomonocytic leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.